Article Text

PDF
P207 Thoracic involvement in IgG4-related disease
  1. RM Anstey1,
  2. JP Corcoran1,
  3. EL Culver2,
  4. A Talwar1,
  5. RJ Hallifax1,
  6. I Psallidas1,
  7. TN Cargill2,
  8. CD Manganis2,
  9. E Barnes2,
  10. NM Rahman1
  1. 1Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK
  2. 2Translational Gastroenterology Unit, Oxford University Hospitals NHS Trust, Oxford, UK

Abstract

Background and objectives IgG4-related disease (IgG4-RD) is a multi-system fibro-inflammatory disorder originally described in association with autoimmune pancreatitis (AIP), usually but not always in the context of elevated serum IgG4 levels. Thoracic manifestations of IgG4-RD include mediastinal lymphadenopathy, lung nodules or masses, interstitial lung disease, bronchiectasis and pleural disease.

The authors’ regional IgG4-RD service is one of the largest UK-based units treating patients with this condition. Specialist clinics and multidisciplinary team meetings operate alongside an active research programme. We aimed to describe the frequency with which thoracic abnormalities – either as a symptomatic presenting feature of IgG4-RD or an incidental asymptomatic finding on imaging – were present in a prospectively recruited patient cohort.

Method and results Patients referred to the authors’ IgG4-RD service from 2005 onwards and confirmed as having a diagnosis of IgG4-RD were included. Diagnoses were made using established clinical criteria (HISORt for AIP and Japanese International Consensus Diagnostic Criteria for systemic disease); tissue specimens were assessed using the Boston histopathological consensus criteria where available. Patients were followed prospectively; clinicopathological data relating to presentation and clinical progress were stored in a secure database with the consent of participants. In patients without symptomatic thoracic manifestations of IgG4-RD, routine clinical imaging (CXR and CT) was reviewed where available for evidence of incidental asymptomatic disease.

61 IgG4-RD patients with thoracic imaging available were included; mean age at diagnosis was 60.3 years (SD 14.6). 43 (70.5%) patients were male. The majority of patients (85.2%) presented with features of intra-abdominal disease. 6 patients (9.8%) had evidence of symptomatic thoracic disease on the basis of clinical presentation, radiology and/or histology. A further 15 (24.6%) patients had abnormal imaging suggestive of asymptomatic thoracic IgG4-RD.

Conclusion A significant proportion of IgG4-RD patients have evidence of symptomatic and asymptomatic thoracic manifestations of this multi-system disease. Respiratory physicians should consider IgG4-RD in their differential diagnosis for a range of pulmonary presentations, particularly where there is co-existing extra-thoracic organ involvement. Making a diagnosis of IgG4-RD impacts on access to established therapeutic options including corticosteroids and rituximab to which the disease is responsive in the inflammatory phase.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.